Bionik Laboratories Market Risk Adjusted Performance
| BNKL Stock | | | USD 0.0001 0.00 0.00% |
The Market Risk Adjusted Performance calculation for Bionik Laboratories draws on price and volume history. Each data point is derived from standardized price and volume feeds. Bionik Laboratories has a market cap of 4.27 M, operating margin of -3.3%, ROE of -7.83%. Use
Trending Equities to explore allocation context. The allocation summary reflects available position data. Composition figures are derived from reported holdings. The allocation shows a weighting toward Bionik Laboratories Corp. The position is captured in the allocation summary. Each holding is sized according to the methodology applied to the portfolio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in industry.
Bionik Laboratories Corp has current Market Risk Adjusted Performance of 0.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | 0 | |
| ER[a] | = | Expected return on investing in Bionik Laboratories |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Market Risk Adjusted Performance Peers Comparison
Market Risk Adjusted Performance Relative To Other Indicators
Bionik Laboratories Corp is rated
below average for market risk adjusted performance within its peer group. It is currently under evaluation for maximum drawdown within its peer group .